Showing results (91-100 of 196) with videos related to
Sort By:
Pageof 20
BMC Pharmacology|May 20, 2004
15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stressTarun K Garg, Jason Y ChangBMC Pharmacology|March 12, 2005
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of drugs - method development and application to magnesium in sheepRichard N Upton, Guy L LudbrookBMC Pharmacology|February 8, 2005
Cross-talk between phosphatidic acid and ceramide during ethanol-induced apoptosis in astrocytesBeate Schatter, Shenchu Jin, Konrad Löffelholz, et al.BMC Pharmacology|October 23, 2004
Peroxynitrite-mediated inactivation of heme oxygenasesRobert Kinobe, Yanbin Ji, Kanji NakatsuBMC Pharmacology|August 20, 2005
In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadineG Howell, L West, C Jenkins, et al.BMC Pharmacology|March 31, 2006
Cyclooxygenase expression is not required for release of arachidonic acid from cells by some nonsteroidal anti-inflammatory drugs and cancer preventive agentsLawrence LevineBMC Pharmacology|December 7, 2007
Chlorin e6 - polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenograftsWilliam W L Chin, Paul W S Heng, Malini OlivoBMC Pharmacology|January 18, 2006
Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytesMartin Ranna, Saku T Sinkkonen, Tommi Möykkynen, et al.BMC Pharmacology|May 14, 2008
RU486 did not exacerbate cytokine release in mice challenged with LPS nor in db/db miceBaichun Yang, Ryan P Trump, Ying Shen, et al.BMC Pharmacology|June 17, 2008
Pharmacological Properties of DOV 315,090, an ocinaplon metaboliteDmytro Berezhnoy, Maria C Gravielle, Scott Downing, et al.Pageof 20